Chidamide Bridging for CAR-T Therapy

Clinical trial NCT05370547 · UNKNOWN

Trial details

NCT number: NCT05370547
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Hodgkin's Lymphoma

Start date: 2022-05-25
Primary completion: 2024-06-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.